Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

CAR-Ts Kymriah and Yescarta step closer to approval in Europe

Final European approval around the corner - but reimbursement and specialist centres among outstanding issues

- PMLiVE

Kate Pogson is named Communiqué’s Healthcare Communications Leader 2018

Judges say Pogson is a "clear leader of the future"

- PMLiVE

UniQure’s starts pivotal haemophilia B gene therapy trial

The treatment could relieve haemophilia B patients from factor IX replacement drugs

- PMLiVE

Amazon shocks pharmacy sector with PillPack deal

Shares in big US pharmacy chains slide on news

- PMLiVE

Healthcare comms appointments

Lucid Group, Wilmington Healthcare and Galliard Healthcare add to their teams

- PMLiVE

Communiqué 2018 – all the winners

Excellence in healthcare communications recognised at awards

Lucid’s magic touch is recognised, winning both Communiqué Medical Education Consultancy of the Year and Communiqué Communications Consultancy of the Year 2018

Lucid’s pioneering and patient-centric approach to strategic medical communications was recognised yesterday as they scooped  a total of four awards. These included: Excellence in Communications via Meetings for OptiMiSe –...

Lucid Group Communications Limited

- PMLiVE

Cutting through the noise

Why creativity = impact in medical education

- PMLiVE

Brexit fears grow for small-to-medium pharma

New survey from EMIG shows sector struggling with uncertainty

- PMLiVE

Daily brief: Global Blood confident of sickle cell success, Breathalyser wins engineering award, Swiss biotech raises funds

The latest from pharma, biotech and healthcare

- PMLiVE

Summit plunges after Duchenne disappointment

UK company to abandon lead molecule after phase II trial failure

- PMLiVE

The Communiqué Awards 2018 – the countdown has begun

New categories recognise excellence in Integrated Non-Promotional Communications, and Communication Through Creative Execution.

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links